5-methoxy-2-methyl-1H-indole-3-carbaldehyde, 95.0%, 100mg

n-(2-Methoxyphenyl)piperidine-4-carboxamide hydrochloride, 97%, 1g

Plan phase S100x/1.25 oil immersion infinity corrected objective

(2H-pyrazolo[4,3-b]pyridin-6-yl)methanamine oxalate, 95%, 100mg

N,N-dibenzyl-1-phenylmethanesulfonamide, 97.0%, 5g

1-(4-Bromo-phenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

1-(furan-2-yl)-3-hydroxy-4-methylpent-2-en-1-one, 98%, 2.5g

2-Chloro-6-methylquinoline-3-carboxaldehyde>96.0%(GC)5g

4-ACETAMIDO-2,5-DIMETHYLBENZENE-1-SULFONYL CHLORIDE, 95.0%, 250mg

Methyl 4-hydroxy-1H-indole-6-carboxylate, 95.0%, 50mg

2-chloro-N-[(furan-2-yl)methyl]-7H-purin-6-amine, 97%, 250mg

z-d-asp-oh, 98.0%, 5g

Cyclopropyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)methanone, 95.0%, 100mg